| Cabotegravir for HIV prevention in cisgender men and transgender women RJ Landovitz, D Donnell, ME Clement, B Hanscom, L Cottle, L Coelho, ... New England Journal of Medicine 385 (7), 595-608, 2021 | 478 | 2021 |
| Feasibility and successful enrollment in a proof-of-concept HIV prevention trial of VRC01, a broadly neutralizing HIV-1 monoclonal antibody S Edupuganti, N Mgodi, ST Karuna, P Andrew, E Rudnicki, N Kochar, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 87 (1), 671-679, 2021 | 21 | 2021 |
| Clinical and immunologic outcomes after immediate or deferred antiretroviral therapy initiation during primary human immunodeficiency virus infection: the Sabes randomized … JR Lama, RAB Ignacio, R Alfaro, J Rios, JG Cartagena, R Valdez, C Bain, ... Clinical Infectious Diseases 72 (6), 1042-1050, 2021 | 18 | 2021 |
| Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and … S Karuna, JA Gallardo-Cartagena, D Theodore, P Hunidzarira, ... Journal of Global Health 13, 2023 | 7 | 2023 |
| Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the … MA Marzinke, B Hanscom, Z Wang, SA Safren, C Psaros, D Donnell, ... The Lancet HIV 10 (11), e703-e712, 2023 | 3 | 2023 |
| Lateral amyotrophic sclerosis-like onset after combined antiretroviral treatment initiation A Quevedo-Ramirez, JJ Montenegro-Idrogo, C Resurrección-Delgado, ... IDCases 22, e00994, 2020 | 2 | 2020 |
| Vibrio cholerae NO-O1/NO-O139 bacteremia in a cirrhotic patient. First case report in Peru and literatura review JA Gallardo-Cartagena, AJ Chiappe-Gonzalez, LM Astocondor-Salazar, ... Revista de Gastroenterologia del Peru: Organo Oficial de la Sociedad de …, 2018 | 2 | 2018 |
| Optimising PrEP uptake and use in Peru: no time to lose! L Menacho, KA Konda, L Lecca, R Cabello, A Lankowski, C Benites, ... The Lancet HIV 11 (4), e204-e206, 2024 | | 2024 |
| Association of HIV pre-exposure prophylaxis (PrEP) use and bacterial sexually transmitted infections (bSTI) among men who have sex with men (MSM) and transgender women (TGW) in … JA Gallardo-Cartagena, P Hunidzarira, K Gillespie, M Juraska, ... International AIDS Society, 2023 | | 2023 |
| RETENTION IN CARE AMONG PERUVIAN MSM AND TGW IN A REAL-WORLD HIV PrEP PROGRAM P Ramírez, AJ Lankowski, JA Gallardo-Cartagena, J Valencia, ... Topics in Antiviral Medicine, 429-429, 2023 | | 2023 |
| SYMPTOM DURATION in COVID-19 CONVALESCENT PATIENTS: REGIONAL & CLINICAL ASSOCIATIONS JA Gallardo-Cartagena, JJ Montenegro-Idrogo, S Li, J Hu, AB Amin, ... Topics in Antiviral Medicine, 37-38, 2022 | | 2022 |
| Sabes: Randomization to Immediate ART Initiation in Acute and Recent HIV Improves Early Clinical and Immunologic Outcomes J Lama, RA Bender Ignacio, R Alfaro, J Rios, JG Cartagena, R Valdez, ... | | 2019 |
